None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Among men and women aged 19 to under 65, those who have experienced headaches in the past six months 2. Those who have confirmed that there are no functional/substrate diseases or clinically meaningful findings through medical history and physical examination 3. Those who voluntarily agree in writing to participate in a clinical study by the patient himself/herself or his/her legal representative
Exclusion criteria
Exclusion criteria: 1. Those who have been evaluated as 56 points or higher through Headache Impact Test-6. 2. Those who are difficult to participate in the study because the participant himself/herself or his/her legal representative do not understand the consent form or do not understand the main contents of the study 3. Those who have a history of neurological diseases (traumatic brain injury, epilepsy, dementia, etc.) or neurological diseases in childhood 4. Those who have psychotic features such as delusions, hallucinations, etc. or have a past history 5. Those who have a systemic disease (e.g., endocrine or metabolic disease) that can affect the central nervous system 6. Those who have a alcohol or substance abuse or dependence 7. Those who take drugs that may affect their headaches and central nervous system (such as migraine drugs, migraine prevention drugs, dementia drugs, thyroid hormones, central nerve stimulants, antipsychotics, anticholinergics, and other psychiatric drugs) 8. An uncontrolled hypertensive patient 9. Those who are pregnant or nursing 10. Those who are currently participating in other clinical trials or participating in other clinical trials within 30 days as of the screening date 11. If the clinical trial investigator determines that the participation of the clinical study is inappropriate MRI specific exclusion criteria 1. If there is a metal substance containing metal in the body (cardio-cerebrovascular stents, artificial pacemakers, cochlear implant, or braces worn, 3 or more implants, etc.) 2. Where it is difficult to endure a confined space due to claustrophobia, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (Headache Impact Test-6, HIT-6) | — |
Secondary
| Measure | Time frame |
|---|---|
| (MIgraine Disability ASsessment, MIDAS);EQ-5D-5L;MRI images and individual analysis results | — |
Countries
Korea, Republic of
Contacts
Kyung Hee University Oriental Medical Center